Reduced FOXO3a expression, orchestrated by DNA methyltransferase 1 (DNMT1), emerges as a driving force for proliferation and tumorigenesis due to increasing the population of breast cancer stem cells [17]. This evidence concerns the gene DNMT1 and breast cancer.